...-related adverse events (irAEs) with multifactorial determinants, complex mechanisms, and varying clinical implications. In specific cancer types, like melanoma, irAEs exhibit a complex relationship with patient outcomes. Case Presentation: We present a case of febrile neutropenia following ICI therapy...

...Ryota Kanno; Yoshitaka Saito; Yoh Takekuma; Hajime Asahina; Mitsuru Sugawara Here, we describe a case of temporary severe neutropenia after atezolizumab monotherapy and its treatment course. Atezolizumab monotherapy was introduced as a 6th-line treatment for a man in his late 60s, who was diagnosed...

...Adam Ethan Prescott; Aditya Ravindra; Asad Javed Neutropenic enterocolitis (NE) is a rare form of inflammatory colitis seen in severely neutropenic patients. Patients with NE typically have severe neutropenia (absolute neutrophil count [ANC] <500/mm 3 ) in the setting of exposure to cytotoxic...

... or intravenous) on other hematological parameters. We report a 29-year-old male patient with iron deficiency anemia, who received oral iron replacement therapy and developed neutropenia which recovered spontaneously 1 month later. However due to ferrous fumarate, the patient developed neutropenia...

... to neutropenia. The incidence of neutropenia is high, and there is no known effective prevention method. Furthermore, the administration method of TAS-102 is complicated. We reported that neutropenia could be avoided by changing to a simple administration method of TAS-102. [email protected] 7 02...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Diabetes mellitus Intraregional injections Magnetic resonance imaging Necrosis Neutropenia Septic shock Shoulder pain...

... cabazitaxel (median: 7 cycles; range: 1–27) under the NPP and were followed until death. Median survival was 14.07 months (1.07–23.80) and progression-free survival was 2.67 months (1.07–20.27). QOL was stable for most patients. Common adverse events (grade ≥3) were neutropenia (n = 8), anaemia (n = 4...

...Jun Osugi; Yuki Owada; Takumi Yamaura; Satoshi Muto; Naoyuki Okabe; Yuki Matsumura; Mitsunori Higuchi; Hiroyuki Suzuki; Mitsukazu Gotoh Crizotinib, the first clinically available inhibitor of anaplastic lymphoma kinase (ALK) gene rearrangement, is generally well tolerated. In contrast, neutropenia...